Skip to main content

Cardlytics Inc

For the period ended Dec 31, 2024. Filed Mar 12, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 12, 2025

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

Year Ended December 31, 2024:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202339,728$9$1,243,594$2,467$(1,111,272)$134,798
Exercise of common stock options6—15——15
Stock-based compensation——45,370——45,370
Issuance of restricted stock3,5031———1
Issuance of common stock, net of issuance cost3,592—27,451——27,451
Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below)3,908—48,151——48,151
Issuance of common stock pursuant to the 2018 ESPP (as defined below)520—2,262——2,262
Termination of capped calls related to 2020 Convertible Senior Notes——115——115
Other comprehensive income———1,134—1,134
Net loss————(189,304)(189,304)
Balance – December 31, 202451,257$10$1,366,958$3,601$(1,300,576)$69,993

Year Ended December 31, 2023:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202233,477$9$1,182,568$5,598$(976,570)$211,605
Exercise of common stock options10—54——54
Stock-based compensation——43,466——43,466
Issuance of restricted stock2,930—————
Issuance of common stock2,755—15,171——15,171
Issuance of common stock under the ESPP556—2,335——2,335
Other comprehensive loss———(3,131)—(3,131)
Net loss————(134,702)(134,702)
Balance – December 31, 202339,728$9$1,243,594$2,467$(1,111,272)$134,798

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Year Ended December 31, 2022:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202133,534$9$1,212,823$486$(522,618)$690,700
Cumulative effect upon adoption of ASU——(51,417)—11,312(40,105)
Exercise of common stock options23—418——418
Stock-based compensation——46,810——46,810
Issuance of restricted stock986—————
Common stock to be issued for the acquisition of Entertainment173—11,937——11,937
Issuance of common stock under the ESPP167—1,997——1,997
Repurchase and cancellation of common stock(1,406)—(40,000)——(40,000)
Other comprehensive loss———5,112—5,112
Net loss————(465,264)(465,264)
Balance – December 31, 202233,477$9$1,182,568$5,598$(976,570)$211,605
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.